Search results for "Zone"

showing 10 items of 2029 documents

Neurobiology

2016

In the adult mammalian brain, neurogenesis occurs in the dentate gyrus (DG) of the hippocampus throughout the life span. Neurogenesis has been extensively characterized in rodents and to a lesser extent in primates. Within the hippocampus, the adult neurogenic niche is specifically located in the subgranular zone of the DG, where neural stem/progenitor cells (NSPCs) reside. It has been confirmed that these stem cells, which possess astrocytic features, give rise to intermediate progenitors, immature neurons, and neurons. The NSPCs have radial glia-like morphology and electrolucid cytoplasm, in contrast to the immature neurons whose cytoplasm is electrodense, containing abundant polyribosome…

medicine.anatomical_structurenervous systemDentate gyrusNeurogenesismedicineHippocampusProgenitor cellBiologyStem cellHippocampal formationGranule cellNeuroscienceSubgranular zone
researchProduct

Reaction of 4-acylaminomethylpyridine N-oxides with phenylbutazone in the presence of acetic anhydride

1987

medicine.drug_classInfraredOrganic ChemistryCarboxamideBiological activityNuclear magnetic resonance spectroscopyAmine oxidechemistry.chemical_compoundAcetic anhydridechemistrymedicinePhenylbutazoneOrganic chemistrymedicine.drugJournal of Heterocyclic Chemistry
researchProduct

The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

2008

Diabetic dyslipidemia is typically characterized by an increase in plasma triglycerides, a decrease in high-density lipoprotein cholesterol and a concomitant increase in atherogenic small dense low-density lipoproteins. Thiazolidindiones are able to lower the levels of fasting glucose and glycated hemoglobin significantly by improving insulin sensitivity, as well as improving some aspects of diabetic dyslipidemia: total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol tend to increase while triglycerides are generally decreased.This paper reviewed the effects of pioglitazone and rosiglitazone on atherogenic diabetic dyslipidemia, in particular on sma…

medicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthType 2 diabetesRosiglitazonechemistry.chemical_compoundDiabetes mellitusInternal medicinemedicine2736 Pharmacology (medical)HumansHypoglycemic AgentsPharmacology (medical)Clinical significancecardiovascular risk dense low-density lipoprotein diabetes low-density lipoprotein size pioglitazone rosiglitazone smallTriglyceridesDyslipidemiasPharmacologyAtherogenic dyslipidemiaPioglitazonebusiness.industryThiazolidindionesAtherogenic dyslipidemiaGeneral Medicinemedicine.diseaseLipoproteins LDLEndocrinology3004 PharmacologychemistryDiabetes Mellitus Type 2lipids (amino acids peptides and proteins)ThiazolidinedionesGlycated hemoglobinbusinessRosiglitazoneLipoproteins HDLPioglitazoneBiomarkersmedicine.drugLipoprotein
researchProduct

COVID-19 and diabetes management: What should be considered?

2020

medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Clinical effectivenessbusiness.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cardiovascular disease COVID-19 Diabetes DPP4 GLP-1RA Hydroxychloroquine Pioglitazone SGLT-2General Medicinemedicine.diseaseEndocrinologyDiabetes managementDiabetes mellitusInternal MedicinemedicineSodium-Glucose Cotransporter 2 InhibitorIntensive care medicinebusinessPioglitazonemedicine.drugDiabetes research and clinical practice
researchProduct

Metabolic syndrome therapy: Prevention of vascular injury by antidiabetic agents

2005

More than 65 million Americans are currently obese. Type 2 diabetes mellitus, frequently seen in obese subjects, affects 17 million adults in the United States, with a continuous and alarmingly increasing rate. To prevent development of diabetes in those who are at high risk, it is recommended to optimize meal planning and enhance physical activity to make sustained weight reduction possible. In addition to lifestyle changes, various oral antidiabetic agents are available, with diverse mechanisms of action. Some target defective insulin secretion (sulphonylureas, benzoic acid derivatives) or glucose absorption (glycosidase inhibitors), whereas others target insulin resistance (metformin, th…

medicine.medical_specialtyAdministration OralType 2 diabetes.PharmacologyInsulin resistanceInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsMetabolic SyndromeHyperplasiabusiness.industryTroglitazoneType 2 Diabetes Mellitusmedicine.diseaseMetforminTreatment OutcomeEndocrinologyBlood VesselsMetabolic syndromebusinessDiabetic AngiopathiesDyslipidemiamedicine.drugCurrent Hypertension Reports
researchProduct

Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants.

2010

Background Pioglitazone (PIO) and rosiglitazone (ROSI) are widely used as oral antidiabetic agents for treatment of type 2 diabetes. Although these medications exert similar effects on blood glucose, recent clinical studies indicated that PIO has a more pronounced beneficial effect on lipid parameters than ROSI. In order to get further insight into the lipid effects of both drugs, we tested whether PIO, compared to ROSI, could exert direct effects on lipid liver metabolism in relation with plasma lipids. Methods We performed in vitro studies using mice liver slices incubated 21 h either with ROSI (1 µmol/L) or PIO (7.5 µmol/L). Results We showed that both glitazones slightly reduced HMG-CoA…

medicine.medical_specialtyApolipoprotein BEndocrinology Diabetes and MetabolismRosiglitazoneTissue Culture Techniqueschemistry.chemical_compoundMiceEndocrinologyInternal medicineInternal MedicinemedicineAnimalsHumansScavenger receptorGlycated HemoglobinbiologyPioglitazoneCholesterolbusiness.industryCholesterol HDLLipid metabolismLipaseLipid MetabolismMice Inbred C57BLPPAR gammaEndocrinologychemistryLiverLipogenesisbiology.proteinThiazolidinedionesHepatic lipaseRosiglitazonebusinessPioglitazonemedicine.drugDiabetes/metabolism research and reviews
researchProduct

Prevalence of ulcerative stomatitis in arbovirus infections in a Brazilian Northeast population

2020

Background Although there are no population-based studies that support an association, there are reports in the literature of mucocutaneous, vesiculobullous and ulcerated lesions in the oral mucosa in cases of arbovirus infection. The aim of this study is to analyze the prevalence of ulcerative stomatitis in individuals affected by arboviruses in a population of the municipality of Arcoverde, Pernambuco, Brazil. Material and Methods 1,003 people living in an area assigned to a Primary Health Care Unit were interviewed. A structured questionnaire was used for data collection, with questions about sociodemographic variables, residence conditions, general health information, as well as informa…

medicine.medical_specialtyArbovirus InfectionsArbovirus infectionsvirusesMucocutaneous zonePopulationArbovirus Infectionsmedicine.disease_causeArbovirusDengue feverZika virusDengue03 medical and health sciences0302 clinical medicineUlcerative StomatitismedicinePrevalenceHumansChikungunyaOral mucosaeducationGeneral DentistryChikungunya fevereducation.field_of_studyOral Medicine and Pathologybusiness.industryResearchvirus diseases030206 dentistrybiochemical phenomena metabolism and nutrition:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseDermatologymedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASChikungunya FeverSurgerybusinessArbovirusesBrazil
researchProduct

PPAR in Cardiovascular Disorders

2016

Peroxisome proliferation-activated receptors (PPARs) are ligand-inducible transcription factors that, upon binding their ligands, translocate into the nucleus, where they regulate transcription of numerous genes that have the peroxisome proliferator response element (PPRE) in the promoter region [1]. In humans, there are 3 PPAR isoforms: PPAR-α, PPAR-β/δ, and PPAR-γ. The isoforms have partially overlapping spectra of activity and are differently expressed in organs and tissues [2]. PPAR-α is expressed mostly in tissues characterized by high catabolic activity, including skeletal muscle, liver, proximal tubular cells in kidneys, and brown fat. This PPAR isoform regulates components of β-oxid…

medicine.medical_specialtyArticle SubjectPeroxisome proliferator-activated receptor030209 endocrinology & metabolism030204 cardiovascular system & hematologyBiology03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDownregulation and upregulationInternal medicineDrug DiscoverymedicineGlucose homeostasisPharmacology (medical)Beta oxidationlcsh:QH301-705.5chemistry.chemical_classificationFatty acid metabolismLipid metabolismPeroxisomeEndocrinologyEditorialchemistrylcsh:Biology (General)Rosiglitazonemedicine.drugPPAR Research
researchProduct

Conservative Surgical Management of Stage I Bisphosphonate-Related Osteonecrosis of the Jaw

2014

Purpose. To report the efficacy of conservative surgical treatment for stage I bisphosphonate-related osteonecrosis of the jaw (BRONJ).Materials and Methods. This study reports the clinical outcomes of 63 patients treated for BRONJ stage I (according to Ruggiero's staging system) at the Oral Pathology and Laser-Assisted Surgery Unit of the University of Parma between January 2004 and January 2011. Surgical interventions were performed, under local analgesia, in patients unresponsive for a period of six months to noninvasive treatments such as cycles of local or systemic antibacterial therapy combined or not to low level laser therapy, ozone therapy, or Hyperbaric Oxygen Therapy. All interve…

medicine.medical_specialtyArticle Subjectbusiness.industrymedicine.medical_treatmentDiseaseBisphosphonatemedicine.diseaseOzone therapySurgerylcsh:RK1-715lcsh:DentistryOral and maxillofacial pathologymedicineClinical StudyIn patientbusinessOsteonecrosis of the jawGeneral DentistryStaging systemLow level laser therapyInternational Journal of Dentistry
researchProduct

Could thiazolidinediones increase the risk of heart failure in Friedreich's ataxia patients?

2011

Clinical evidence and the recent decisions of the European Medicines Agency and the Food and Drug Administration challenge the safety of thiazolidinediones treatment. Recently, this treatment has been suggested for Friedreich's ataxia because thiazolidinediones improve neurological symptoms. Hypertrophic cardiomyopathy is the most prevalent cardiac feature and the cause of premature death in Friedreich's ataxia patients. We recommend that therapy with peroxisome proliferator-activated receptor-gamma agonists like thiazolidinediones be taken with caution, as they cause a decrease in the number of fast fibers and an increase in mitochondrial biogenesis in cardiac muscle because of the inducti…

medicine.medical_specialtyAtaxiaHeart diseasebusiness.industryInsulinmedicine.medical_treatmentHypertrophic cardiomyopathymedicine.diseaseBioinformaticsEndocrinologyNeurologyMitochondrial biogenesisHeart failureInternal medicinemedicineNeurology (clinical)medicine.symptomRosiglitazonebusinessPioglitazonemedicine.drugMovement Disorders
researchProduct